Vaccine Delivery Devices Market
Vaccine Delivery Devices Market Size And Forecast
Vaccine Delivery Devices Market was valued at USD 3.5 Billion in 2018 and is projected to reach USD 5.7 Billion by 2026, growing at a CAGR of 6.2% from 2019 to 2026.
Global Vaccine Delivery Devices Market Outlook
The key factors projected to stimulate the growth of the vaccine delivery devices market are needle free delivery systems, as these systems have potential to decrease the dose of the vaccine antigen and also enhances the vaccine immunogenicity. Moreover, rapid advancement of technology in systematic delivery of vaccines such as micro-needles and electroporation is further expected to bolster the market growth. The factor such as the vaccines delivered through micro-needles into the dermis affects faster than the intra-muscular injections, also augments the market growth. On the flip side, the cost of the micro-needles especially in the emerging countries is one of the major factor restricting the market growth
Global Vaccine Delivery Devices Market Competitive Landscape
The Global Vaccine Delivery Devices Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as 3M, Becton Dickinson & Company, Gerresheimer AG, Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.), SCHOTT AG, Valeritas, PharmaJet; Vaxxas, and Corium International, Inc.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.